WallStSmart

CareTrust REIT Inc. (CTRE)vsHealthpeak Properties Inc (DOC)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Healthpeak Properties Inc generates 416% more annual revenue ($2.95B vs $571.43M). CTRE leads profitability with a 62.2% profit margin vs 8.3%. CTRE appears more attractively valued with a PEG of 1.26. CTRE earns a higher WallStSmart Score of 70/100 (B).

CTRE

Strong Buy

70

out of 100

Grade: B

Growth: 8.7Profit: 8.0Value: 7.3Quality: 6.5
Piotroski: 3/9Altman Z: 2.46

DOC

Buy

58

out of 100

Grade: C

Growth: 8.0Profit: 5.5Value: 4.7Quality: 4.5
Piotroski: 2/9Altman Z: 0.22
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CTREUndervalued (+33.9%)

Margin of Safety

+33.9%

Fair Value

$59.55

Current Price

$36.39

$23.16 discount

UndervaluedFair: $59.55Overvalued
DOCUndervalued (+38.1%)

Margin of Safety

+38.1%

Fair Value

$27.40

Current Price

$19.03

$8.37 discount

UndervaluedFair: $27.40Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CTRE5 strengths · Avg: 9.4/10
Profit MarginProfitability
62.2%10/10

Keeps 62 of every $100 in revenue as profit

Operating MarginProfitability
64.9%10/10

Strong operational efficiency at 64.9%

Revenue GrowthGrowth
43.5%10/10

Revenue surging 43.5% year-over-year

Debt/EquityHealth
0.279/10

Conservative balance sheet, low leverage

Price/BookValuation
1.9x8/10

Reasonable price relative to book value

DOC2 strengths · Avg: 9.0/10
EPS GrowthGrowth
68.2%10/10

Earnings expanding 68.2% YoY

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

Areas to Watch

CTRE1 concerns · Avg: 3.0/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

DOC4 concerns · Avg: 2.8/10
Return on EquityProfitability
3.2%3/10

ROE of 3.2% — below average capital efficiency

Debt/EquityHealth
1.323/10

Elevated debt levels

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

PEG RatioValuation
4.082/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : CTRE

The strongest argument for CTRE centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 62.2% and operating margin at 64.9%. Revenue growth of 43.5% demonstrates continued momentum.

Bull Case : DOC

The strongest argument for DOC centers on EPS Growth, Price/Book. Revenue growth of 11.1% demonstrates continued momentum.

Bear Case : CTRE

The primary concerns for CTRE are Piotroski F-Score.

Bear Case : DOC

The primary concerns for DOC are Return on Equity, Debt/Equity, Piotroski F-Score. A P/E of 55.7x leaves little room for execution misses.

Key Dynamics to Monitor

CTRE profiles as a growth stock while DOC is a value play — different risk/reward profiles.

DOC carries more volatility with a beta of 0.99 — expect wider price swings.

CTRE is growing revenue faster at 43.5% — sustainability is the question.

CTRE generates stronger free cash flow (130M), providing more financial flexibility.

Bottom Line

CTRE scores higher overall (70/100 vs 58/100), backed by strong 62.2% margins and 43.5% revenue growth. DOC offers better value entry with a 38.1% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CareTrust REIT Inc.

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

CareTrust REIT, Inc. is a publicly traded, self-managed real estate investment trust engaged in the ownership, acquisition, development, and leasing of skilled nursing, senior housing, and other healthcare-related properties.

Visit Website →

Healthpeak Properties Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Physicians Realty Trust is a self-managed healthcare real estate company organized to acquire, selectively develop, own and manage healthcare properties that are rented to physicians, hospitals and healthcare delivery systems.

Visit Website →

Want to dig deeper into these stocks?